Auf dieser Seite
ATRA Atara Biotherapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$9,48
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,9252-Wochen-Tief
$19,1552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$90M
P/E (TTM)
-5.5
EPS (TTM)
$-1.73
Umsatz (TTM)
$6M
Ihre Abzeichen
52W-Spanne
$4–$19
Analystenbewertung
BUY
Kursziel
$14
P/E
-5.5
ROE
46.3%
Nettogewinnmarge
-269.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ATRA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.48
Marktkapitalisierung (MRQ)
$90M
P/E (TTM)
-5.5
EPS (TTM)
$-1.73
Umsatz (TTM)
$6M
ROE (TTM)
46.3%
52W-Spanne
$4–$19
ATRA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 20. Juni 2024 | 1-for-25 | Umgekehrt |
Über Atara Biotherapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter10
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$121M2022-12-31 → 2025-12-31
EPS$2.572020-12-31 → 2025-12-31
Freier Cashflow$-51M2016-12-31 → 2025-12-31
Nettogewinnmarge-269.4%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ATRA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -5.55-Jahres-Durchschnitt ≈-27.9 | ≈-27.9 | · | · | |
| P/S (TTM) | 14.55-Jahres-Durchschnitt ≈71.2 | ≈71.2 | 70.6 | Unterbewertet | |
| K/B (MRQ) | -2.45-Jahres-Durchschnitt ≈34.7 | ≈34.7 | · | · | |
| Price / FCF (Kurs / FCF) | -1.45-Jahres-Durchschnitt ≈-39.1 | ≈-39.1 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -1.45-Jahres-Durchschnitt ≈-40.7 | ≈-40.7 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 7.25-Jahres-Durchschnitt ≈68.3 | ≈68.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ATRA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -229.7%5-Jahres-Durchschnitt ≈-1084.8% | ≈-1084.8% | -2434.3% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | 29.7%5-Jahres-Durchschnitt ≈-1084.8% | ≈-1084.8% | -2434.3% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -269.0%5-Jahres-Durchschnitt ≈-1086.6% | ≈-1086.6% | -3416.0% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -269.4%5-Jahres-Durchschnitt ≈-1086.7% | ≈-1086.7% | -2336.0% | Spitzenklasse | |
| ROA (TTM) | -57.6%5-Jahres-Durchschnitt ≈-46.4% | ≈-46.4% | -30.1% | Spitzenklasse | |
| ROE (TTM) | 46.3%5-Jahres-Durchschnitt ≈21.8% | ≈21.8% | -50.0% | Schwach | |
| ROIC | -93.0%5-Jahres-Durchschnitt ≈-14.5% | ≈-14.5% | -52.7% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ATRA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.05-Jahres-Durchschnitt ≈1.9 | ≈1.9 | 5.3 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 1.55-Jahres-Durchschnitt ≈1.7 | ≈1.7 | 3.8 | Geringe Liquidität | |
| Interest Coverage (Zinsdeckungsgrad) | 9.55-Jahres-Durchschnitt ≈-20.3 | ≈-20.3 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ATRA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -6.3%5-Jahres-Durchschnitt ≈437.1% | ≈437.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 23.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ATRA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.95-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 0.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 88.35-Jahres-Durchschnitt ≈31.9 | ≈31.9 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$12.1M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
76.0%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.32 | $-0.32 | 0.40% |
| 31. März 2026 | Mai 13, 2026 | $-0.29 | $-0.41 | 29.8% |
| 31. Dezember 2025 | $-0.25 | $-0.17 | -43.0% | |
| 30. September 2025 | $-0.32 | $-0.88 | 63.5% | |
| 30. Juni 2025 | $0.19 | $-0.47 | 140.5% | |
| 31. März 2025 | $3.50 | $-2.02 | 273.3% | |
| 31. Dezember 2024 | $-1.19 | $-3.65 | 67.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $121M | $129M | $9M | $64M | |
| R&D Expense | $37M | $151M | $225M | $273M | |
| SG&A Expense | $26M | $40M | $51M | $72M | |
| Operating Expenses | $85M | $212M | $285M | $344M | |
| Operating Income | $36M | $-83M | $-276M | $-281M | |
| Interest Expense | $4M | $5M | $5M | $373.0K | |
| Interest Income | $683.0K | $2M | $5M | $3M | |
| Other Non-op | $-34.0K | $528.0K | $-246.0K | $-700.0K | |
| Pretax Income | $33M | $-85M | $-276M | $-228M | |
| Income Tax | $31.0K | $-12.0K | $15.0K | $12.0K | |
| Net Income | $33M | $-85M | $-276M | $-228M | |
| EPS (Basic) | $2.61 | $-11.41 | $-65.19 | $-2.24 | |
| EPS (Diluted) | $2.57 | $-11.41 | $-65.19 | $-2.24 | |
| Shares (Basic) | 12,544,000 | 7,488,000 | 4,236,000 | 101,990,000 | |
| Shares (Diluted) | 12,718,000 | 7,488,000 | 4,236,000 | 101,990,000 | |
| EBITDA | $36M | $-83M | $-276M | $-281M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $25M | $26M | $93M | |
| Short-term Investments | $0 | $17M | $26M | $150M | |
| Receivables | $1M | $1M | $34M | $40M | |
| Inventory | $0 | $11M | $10M | $2M | |
| Other Current Assets | $2M | $10M | $6M | $10M | |
| Current Assets | $12M | $65M | $102M | $295M | |
| PP&E (Net) | $73.0K | $1M | $4M | $6M | |
| PP&E (Gross) | $286.0K | $19M | $20M | $19M | |
| Accum. Depreciation | $213.0K | $17M | $16M | $12M | |
| Other Non-current Assets | $886.0K | $3M | $5M | $7M | |
| Total Assets | $20M | $109M | $166M | $376M | |
| Accounts Payable | $127.0K | $4M | $4M | $7M | |
| Accrued Liabilities | $2M | $6M | $19M | $7M | |
| Current Liabilities | $15M | $135M | $142M | $79M | |
| Capital Leases | $9M | $30M | $46M | $58M | |
| Other Non-current Liabilities | $2M | $3M | $5M | $6M | |
| Total Liabilities | $59M | $206M | $265M | $250M | |
| Common Stock | $1.0K | $1.0K | $0 | $10.0K | |
| Retained Earnings | $-2.02B | $-2.05B | $-1.97B | $-1.69B | |
| AOCI | $1.0K | $8.0K | $-204.0K | $-2M | |
| Stockholders' Equity | $-39M | $-97M | $99M | $127M | |
| Liabilities + Equity | $20M | $109M | $166M | $376M | |
| Shares Outstanding | 7,324,000 | 5,859,000 | 4,258,000 | 95,927,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $2M | $5M | $5M | $6M | |
| Stock-based Comp | $10M | $27M | $45M | $54M | |
| Deferred Tax | $0 | $0 | · | · | |
| Restructuring | $13M | $5M | $7M | $6M | |
| Operating Cash Flow | $-51M | $-69M | $-193M | $-270M | |
| CapEx | $0 | $246.0K | $1M | $4M | |
| Investing Cash Flow | $18M | $9M | $124M | $203M | |
| Stock Issued | $1M | $9M | $2M | $22M | |
| Net Stock Activity | $1M | $9M | $2M | $22M | |
| Financing Cash Flow | $16M | $59M | $2M | $53M | |
| Taxes Paid | $190.0K | $24.0K | $2.0K | $19.0K | |
| Free Cash Flow | $-51M | $-69M | $-194M | $-275M | |
| Levered FCF | $-55M | $-74M | $-199M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | 29.7% | -64.7% | -3219.5% | · | |
| Net Margin | 27.1% | -66.2% | -3220.9% | · | |
| Pretax Margin | 27.1% | -66.2% | -3220.7% | · | |
| EBITDA Margin | 29.7% | -64.7% | -3219.5% | · | |
| ROA | 50.5% | -62.2% | -101.9% | -54.1% | |
| ROE | -88.9% | 90.9% | 368.0% | -145.5% | |
| ROIC | -93.0% | 85.8% | 278.2% | -221.5% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.5 | 0.7 | 3.7 | |
| Quick Ratio | 0.7 | 0.3 | 0.6 | 3.6 | |
| Interest Coverage | 9.5 | -18.1 | -52.2 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 1.9 | 0.9 | 0.0 | · | |
| Receivables Turnover | 88.3 | 7.2 | 0.2 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $-5.26 | $-16.60 | $-0.93 | $1.32 | |
| Revenue / Share | $9.50 | $17.22 | $0.08 | · | |
| Cash Flow / Share | $-4.01 | $-9.18 | $-1.82 | $-2.65 | |
| Cash / Share | $1.16 | $4.27 | $0.24 | $0.97 | |
| EPS (TTM) | $2.57 | $-11.41 | $-65.19 | $-2.24 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -6.3% | 1404.0% | -86.5% | · | |
| Revenue CAGR 3Y | 23.8% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $121M | $129M | $9M | $64M | |
| Net Income TTM | $33M | $-85M | $-276M | $-228M | |
| Market Cap | $132M | $78M | $1.37B | $7.87B | |
| P/E | 7.0 | -1.2 | -0.2 | -36.6 | |
| P/S | 1.1 | 0.6 | 159.2 | 123.7 | |
| P/B | -3.4 | -0.8 | -13.8 | 62.1 | |
| P / Tangible Book | · | · | 13.8 | 62.1 | |
| P / Cash Flow | -2.6 | -1.1 | -7.1 | -29.1 | |
| P / FCF | -2.6 | -1.1 | -7.0 | -28.6 | |
| Earnings Yield | 14.2% | -85.7% | -508.3% | -2.7% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $630.0K | $516.0K | $2M | $3M | $18M | $98M | $33M | $40M | $29M | $27M | $4M | $2M | $957.0K | $1M | $221.0K | $4M | |
| R&D Expense | $1M | $164.0K | $-223.0K | $3M | $7M | $27M | $29M | $44M | $33M | $46M | $50M | $57M | $56M | $62M | $63M | $70M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $7M | $11M | $9M | $10M | $9M | $11M | $11M | $12M | $13M | $14M | $13M | $19M | |
| Operating Expenses | $5M | $4M | $4M | $7M | $14M | $59M | $45M | $62M | $47M | $59M | $64M | $72M | $72M | $76M | $76M | $89M | |
| Operating Income | $-5M | $-3M | $-3M | $-4M | $3M | $39M | $-12M | $-22M | $-18M | $-31M | $-60M | $-70M | $-71M | $-75M | $-76M | $-85M | |
| Interest Expense | $191.0K | $830.0K | $894.0K | $909.0K | $972.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $117.0K | $123.0K | |
| Interest Income | $78.0K | $54.0K | $100.0K | $204.0K | $143.0K | $236.0K | $597.0K | $459.0K | $450.0K | $604.0K | $711.0K | $1M | $2M | $2M | $1M | $973.0K | |
| Other Non-op | $0 | $0 | $-49.0K | $4.0K | $22.0K | $-11.0K | $-89.0K | $555.0K | $-6.0K | $68.0K | $-12.0K | $-27.0K | $-10.0K | $-197.0K | $-68.0K | $-309.0K | |
| Pretax Income | $-5M | $-4M | $-3M | $-4M | $2M | $38M | $-13M | $-22M | $-19M | $-32M | $-60M | $-70M | $-71M | $-75M | $-75M | $-84M | |
| Income Tax | $1.0K | $0 | $0 | $28.0K | $3.0K | $0 | $-19.0K | $-17.0K | $0 | $24.0K | $11.0K | $-19.0K | $1.0K | $22.0K | $2.0K | $10.0K | |
| Net Income | $-5M | $-4M | $-3M | $-4M | $2M | $38M | $-13M | $-22M | $-19M | $-32M | $-60M | $-70M | $-71M | $-75M | $-75M | $-84M | |
| EPS (Basic) | $-0.32 | $-0.29 | $-0.80 | $-0.32 | $0.20 | $3.53 | $0.27 | $-2.93 | $-3.10 | $-5.65 | $-31.16 | $-16.40 | $-16.91 | $-0.72 | $-0.73 | $-0.82 | |
| EPS (Diluted) | $-0.32 | $-0.29 | $-0.80 | $-0.32 | $0.19 | $3.50 | $0.27 | $-2.93 | $-3.10 | $-5.65 | $-31.16 | $-16.40 | $-16.91 | $-0.72 | $-0.73 | $-0.82 | |
| Shares (Basic) | 15,033,000 | 14,081,000 | · | 13,564,000 | 12,197,000 | 10,764,000 | · | 7,466,000 | 6,143,000 | 5,623,000 | · | 4,256,000 | 4,204,000 | 103,969,000 | · | 102,423,000 | |
| Shares (Diluted) | 15,033,000 | 14,081,000 | · | 13,564,000 | 12,310,000 | 10,851,000 | · | 7,466,000 | 6,143,000 | 5,623,000 | · | 4,256,000 | 4,204,000 | 103,969,000 | · | 102,423,000 | |
| EBITDA | · | $-3M | · | $-4M | $3M | $39M | · | $-22M | $-18M | $-31M | · | $-70M | $-71M | $-75M | · | $-85M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $8M | $8M | $6M | $17M | $14M | $25M | $46M | $31M | $35M | $26M | $65M | $46M | $49M | $93M | $65M | |
| Short-term Investments | $7M | · | $0 | $8M | $5M | $0 | $17M | $21M | $4M | $11M | $26M | $38M | $108M | $157M | $150M | $200M | |
| Receivables | $318.0K | $0 | $1M | $2M | $0 | $9M | $1M | $1M | $2M | $36M | $34M | $163.0K | $507.0K | $397.0K | $40M | $249.0K | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $11M | $14M | $19M | $16M | $10M | $7M | $8M | $5M | $2M | · | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $16M | |
| Other Current Assets | $3M | $4M | $2M | $3M | $2M | $4M | $10M | $9M | $6M | $8M | $6M | $9M | $10M | $13M | $10M | · | |
| Current Assets | $14M | $12M | $12M | $18M | $25M | $27M | $65M | $92M | $62M | $106M | $102M | $119M | $172M | $224M | $295M | $283M | |
| PP&E (Net) | $41.0K | $55.0K | $73.0K | $147.0K | $176.0K | $285.0K | $1M | $2M | $2M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | |
| PP&E (Gross) | · | · | $286.0K | $551.0K | $551.0K | $2M | $19M | $20M | $20M | $20M | $20M | $20M | $20M | $19M | $19M | $20M | |
| Accum. Depreciation | · | · | $213.0K | $404.0K | $375.0K | $2M | $17M | $18M | $17M | $17M | $16M | $15M | $14M | $13M | $12M | $12M | |
| Other Non-current Assets | $765.0K | $890.0K | $886.0K | $881.0K | $927.0K | $3M | $3M | $3M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $7M | |
| Total Assets | $21M | $20M | $20M | $30M | $37M | $62M | $109M | $143M | $117M | $165M | $166M | $189M | $246M | $302M | $376M | $368M | |
| Accounts Payable | $824.0K | $637.0K | $127.0K | $318.0K | $2M | $1M | $4M | $2M | $5M | $3M | $4M | $7M | $4M | $5M | $7M | $11M | |
| Accrued Liabilities | $2M | $2M | $2M | $3M | $5M | $9M | $6M | $8M | $11M | $18M | $19M | $8M | $11M | $7M | $7M | · | |
| Current Liabilities | $7M | $6M | $15M | $18M | $15M | $48M | $135M | $156M | $148M | $181M | $142M | $79M | $75M | $68M | $79M | $72M | |
| Capital Leases | $9M | $9M | $9M | $15M | $15M | $27M | $30M | $35M | $39M | $42M | $46M | $49M | $52M | $55M | $58M | $61M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | |
| Total Liabilities | $58M | $57M | $59M | $67M | $72M | $117M | $206M | $233M | $228M | $264M | $265M | $240M | $239M | $237M | $250M | $181M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $12.0K | $0 | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | |
| Retained Earnings | $-2.03B | $-2.03B | $-2.02B | $-2.02B | $-2.01B | $-2.02B | $-2.05B | $-2.04B | $-2.02B | $-2.00B | $-1.97B | $-1.91B | $-1.84B | $-1.77B | $-1.69B | $-1.62B | |
| AOCI | $-2.0K | $0 | $1.0K | $2.0K | $0 | $0 | $8.0K | $22.0K | $-14.0K | $-55.0K | $-204.0K | $-571.0K | $-933.0K | $-1M | $-2M | $-3M | |
| Stockholders' Equity | $-37M | $-37M | $-39M | $-37M | $-35M | $-55M | $-97M | $-91M | $-111M | $-98M | $-99M | $-51M | $7M | $65M | $127M | $187M | |
| Liabilities + Equity | $21M | $20M | $20M | $30M | $37M | $62M | $109M | $143M | $117M | $165M | $166M | $189M | $246M | $302M | $376M | $368M | |
| Shares Outstanding | 9,443,000 | 8,512,000 | 7,324,000 | 7,210,000 | 6,978,000 | 5,924,000 | 5,859,000 | 5,740,000 | 4,904,000 | 120,325,000 | 4,258,000 | 101,922,000 | 101,102,000 | 96,538,000 | 95,927,000 | 94,879,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $14.0K | $29.0K | $49.0K | $36.0K | $236.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $394.0K | $749.0K | $2M | $1M | $3M | $4M | $6M | $6M | $6M | $8M | $10M | $11M | $13M | $12M | $11M | $14M | |
| Restructuring | $767.0K | $0 | $1M | $27.0K | $2M | $10M | $0 | $0 | $356.0K | $5M | $7M | $0 | $0 | $45.0K | $74.0K | $6M | |
| Operating Cash Flow | $-3M | $-3M | $-6M | $-10M | $-7M | $-28M | $-24M | $-4M | $-11M | $-30M | $-50M | $-51M | $-53M | $-38M | $-57M | $-65M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $90.0K | $0 | $29.0K | $127.0K | $44.0K | $281.0K | $499.0K | $399.0K | $37.0K | $132.0K | |
| Investing Cash Flow | $-7M | $0 | $8M | $-2M | $-5M | $17M | $3M | $-17M | $7M | $15M | $10M | $70M | $49M | $-6M | $51M | $60M | |
| Stock Issued | $5M | $3M | $-25.0K | $1M | $0 | $0 | $0 | $0 | $-26.0K | $9M | $2M | $0 | $-50.0K | $640.0K | $1M | $0 | |
| Net Stock Activity | · | $3M | · | · | · | $0 | · | · | · | $9M | · | · | · | $640.0K | · | · | |
| Financing Cash Flow | $5M | $3M | $-3.0K | $1M | $15M | $-250.0K | $-328.0K | $36M | $-324.0K | $24M | $2M | $-208.0K | $471.0K | $235.0K | $32M | $-214.0K | |
| Taxes Paid | · | · | $159.0K | $28.0K | $3.0K | $0 | $0 | $0 | $0 | $24.0K | $0 | $0 | $1.0K | $1.0K | $0 | $0 | |
| Free Cash Flow | · | · | · | · | · | $-28M | · | · | · | $-30M | · | · | · | $-39M | · | · | |
| Levered FCF | · | · | · | · | · | $-29M | · | · | · | $-31M | · | · | · | $-40M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -652.9% | · | -103.5% | 18.2% | 39.5% | · | -54.1% | -63.7% | -114.2% | · | -3255.9% | -7462.3% | -6118.9% | · | · | |
| Net Margin | · | -803.3% | · | -124.6% | 13.6% | 38.7% | · | -54.5% | -66.5% | -116.1% | · | -3264.6% | -7430.3% | -6098.8% | · | · | |
| Pretax Margin | · | -803.3% | · | -123.8% | 13.6% | 38.7% | · | -54.6% | -66.5% | -116.0% | · | -3265.5% | -7430.2% | -6097.0% | · | · | |
| EBITDA Margin | · | -652.9% | · | -103.5% | 18.2% | 39.5% | · | -54.1% | -63.7% | -114.2% | · | -3255.9% | -7462.3% | -6118.9% | · | · | |
| ROA | · | -10.1% | · | -5.0% | 3.1% | 33.4% | · | -13.2% | -10.5% | -13.6% | · | -25.1% | -20.8% | -21.4% | · | -20.5% | |
| ROE | · | 9.0% | · | 6.8% | -3.3% | -49.6% | · | 31.0% | 36.8% | 190.4% | · | -102.4% | -53.7% | -51.7% | · | -33.8% | |
| ROIC | · | 9.0% | · | 9.8% | -9.1% | -70.5% | · | 24.0% | 16.4% | 31.8% | · | 136.9% | -958.1% | -115.5% | · | -45.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.2 | · | 1.0 | 1.7 | 0.6 | · | 0.6 | 0.4 | 0.6 | · | 1.5 | 2.3 | 3.3 | · | 3.9 | |
| Quick Ratio | · | 1.5 | · | 0.9 | 1.5 | 0.5 | · | 0.4 | 0.3 | 0.5 | · | 1.3 | 2.1 | 3.0 | · | 3.7 | |
| Interest Coverage | · | -4.1 | · | -3.9 | 3.3 | 38.2 | · | -18.4 | -14.4 | -27.1 | · | -49.9 | -51.8 | -56.2 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.0 | 0.2 | 0.9 | · | 0.2 | 0.2 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | · | 0.1 | · | 2.1 | 14.5 | 4.4 | · | 53.7 | 19.6 | 1.5 | · | 10.4 | 1.7 | 2.3 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $-4.38 | · | $-5.08 | $-5.02 | $-9.30 | · | $-15.77 | $-22.61 | $-0.82 | · | $-0.50 | $0.07 | $0.67 | · | $1.97 | |
| Revenue / Share | · | $0.04 | · | $0.25 | $1.43 | $9.05 | · | $5.38 | $4.66 | $0.19 | · | $0.02 | $0.01 | $0.01 | · | · | |
| Cash Flow / Share | · | $-0.22 | · | · | · | $-2.59 | · | · | · | $-0.21 | · | · | · | $-0.37 | · | · | |
| Cash / Share | · | $0.98 | · | $0.80 | $2.42 | $2.34 | · | $8.09 | $6.39 | $0.29 | · | $0.64 | $0.45 | $0.50 | · | $0.69 | |
| EPS (TTM) | $-0.74 | $-1.22 | · | $3.64 | $1.03 | $-2.26 | · | $-42.84 | $-56.31 | $-70.12 | · | $-34.76 | $-19.18 | $-2.09 | · | $-2.47 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $23M | · | $152M | $189M | $200M | · | $100M | $62M | $35M | · | $5M | $7M | $57M | · | · | |
| Net Income TTM | $-11M | $-9M | · | $23M | $6M | $-16M | · | $-133M | $-181M | $-233M | · | $-290M | $-305M | $-215M | · | $-247M | |
| Market Cap | · | $40M | · | $103M | $54M | $35M | · | $47M | $42M | $2.09B | · | $3.77B | $4.07B | $7.00B | · | $8.97B | |
| P/E | -15.5 | -3.9 | · | 3.9 | 7.5 | -2.6 | · | -0.2 | -0.2 | -0.2 | · | -1.1 | -2.1 | -34.7 | · | -38.3 | |
| P/S | · | 1.7 | · | 0.7 | 0.3 | 0.2 | · | 0.5 | 0.7 | 60.2 | · | 830.3 | 592.9 | 121.8 | · | · | |
| P/B | · | -1.1 | · | -2.8 | -1.5 | -0.6 | · | -0.5 | -0.4 | -21.2 | · | -74.2 | 545.9 | 107.7 | · | 47.9 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 545.9 | 107.7 | · | 47.9 | |
| P / Cash Flow | · | -13.1 | · | · | · | -1.3 | · | · | · | -70.5 | · | · | · | -182.1 | · | · | |
| Earnings Yield | -6.5% | -25.8% | · | 25.4% | 13.3% | -38.0% | · | -526.9% | -662.5% | -404.2% | · | -94.0% | -47.6% | -2.9% | · | -2.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $121M | $129M | $9M | $64M | · |
| Betriebsgewinnmarge % | 29.7% | -64.7% | -3219.5% | · | · |
| Nettoergebnis | $33M | $-85M | $-276M | $-228M | $-340M |
| Verwässerte EPS | $2.57 | $-11.41 | $-65.19 | $-2.24 | $-3.63 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 0.8 | 0.5 | 0.7 | 3.7 | 3.6 |
| Quick Ratio | 0.7 | 0.3 | 0.6 | 3.6 | 3.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-51M | $-69M | $-194M | $-275M | $-231M |
Institutionelle Eigentümer (13F) 38 Einreicher · $54.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
38
Gehaltener Wert
$54.9M
Neue Positionen
4
Geschlossene Positionen
1
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 4 (-3 vs. Vorquartal) | 1 (-13 vs. Vorquartal) | 12 (+2 vs. Vorquartal) | 8 (+5 vs. Vorquartal) | +1.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $17.816.960 | 1.552.000 | 32,43% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $9.758.000 | 850.000 | 17,76% | Aktien |
| Point72 Asset Management, L.P. | $7.895.003 | 687.718 | 14,37% | Aktien |
| Redmile Group, LLC | $5.070.727 | 441.701 | 9,23% | Aktien |
| VANGUARD GROUP INC | $4.087.255 | 225.940 | 7,44% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.836.100 | 247.047 | 5,16% | Aktien |
| MACKENZIE FINANCIAL CORP | $2.677.699 | 233.249 | 4,87% | Aktien |
| BlackRock, Inc. | $969.544 | 84.455 | 1,76% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $862.924 | 75.128 | 1,57% | Aktien |
| STALEY CAPITAL ADVISERS INC | $574.000 | 50.000 | 1,04% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $494.053 | 43.036 | 0,90% | Aktien |
| JANE STREET GROUP, LLC | $348.360 | 30.345 | 0,63% | Aktien |
| STATE STREET CORP | $303.680 | 26.453 | 0,55% | Aktien |
| NORTHERN TRUST CORP | $190.465 | 16.591 | 0,35% | Aktien |
| FMR LLC | $186.412 | 16.238 | 0,34% | Aktien |
| XTX Topco Ltd | $175.678 | 15.303 | 0,32% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $160.720 | 14.000 | 0,29% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $145.566 | 12.680 | 0,26% | Aktien |
| CITADEL ADVISORS LLC | $116.625 | 10.159 | 0,21% | Aktien |
| MORGAN STANLEY | $105.368 | 9.178 | 0,19% | Aktien |
| ROYAL BANK OF CANADA | $55.000 | 4.743 | 0,10% | Aktien |
| UBS Group AG | $45.679 | 3.979 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $16.715 | 1.456 | 0,03% | Aktien |
| SBI Securities Co., Ltd. | $16.118 | 1.404 | 0,03% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $8.440 | 803 | 0,02% | Aktien |
| Caitong International Asset Management Co., Ltd | $3.570 | 311 | 0,01% | Aktien |
| BARCLAYS PLC | $3.490 | 304 | 0,01% | Aktien |
| Banque Transatlantique SA | $3.096 | 176 | 0,01% | Aktien |
| WELLS FARGO & COMPANY/MN | $2.881 | 251 | 0,01% | Aktien |
| JPMORGAN CHASE & CO | $2.413 | 216 | 0,00% | Aktien |
| Raiffeisen Bank International AG | $2.296 | 200 | 0,00% | Kaufoption |
| CITIGROUP INC | $1.114 | 97 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $528 | 46 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $444 | 38.845 | 0,00% | Aktien |
| PlanVest Financial, Inc | $321 | 28 | 0,00% | Aktien |
| KERR FINANCIAL PLANNING Corp | $276 | 24 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $114 | 10 | 0,00% | Aktien |
| Rockefeller Capital Management L.P. | $92 | 8 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Redmile Group, LLC, Green Jeremy, Redmile Biopharma Investments II, L.P., Redmile Strategic Long Only Trading Sub, Ltd. ×4 Einreichungen | 24. Juli 2026 | 9,90% | Änderung | · | SEC |
| Panacea Innovation Limited, Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., Panacea Opportunity Fund I, L.P., Panacea Opportunity Fund I GP Company, Ltd., James Huang ×4 Einreichungen | 11. Mai 2026 | 16,10% | Änderung | · | SEC |
| Adiumentum Capital Fund I LP, Adiumentum Capital Fund I GP LLC, Gregory A. Ciongoli ×3 Einreichungen | 16. Mai 2025 | 19,99% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 35 Insider · 19 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Anhco Nguyen | President and CEO | 17. August 2026 S | 132.775 | 0 | 8 | $-142.448 |
| Isaac E. Ciechanover | Chief Executive Officer | 30. Mai 2019 S | 290.687 | 0 | 0 | $0 |
| Utpal Koppikar | Chief Financial Officer | 2. März 2023 S | 181.978 | 0 | 0 | $0 |
| John Mcgrath | EVP & Chief Financial Officer | 20. März 2018 S | 88.762 | 0 | 0 | $0 |
| Yanina Grant-Huerta | Chief Accounting Officer | 18. Mai 2026 S | 49.636 | 0 | 8 | $-56.523 |
| Jill Henrich | EVP, Chief Regulatory Officer | 3. März 2025 S | 18.679 | 0 | 0 | $0 |
| Amar Murugan | EVP, Chief Legal Officer | 16. August 2024 S | 26.827 | 0 | 0 | $0 |
| Manher Joshi | EVP, Chief Medical Officer | 16. November 2023 S | 171.284 | 0 | 0 | $0 |
| Charlene A. Banard | EVP, Chief Technical Officer | 16. Mai 2023 S | 276.010 | 0 | 0 | $0 |
| Jakob Dupont | EVP, Head of R&D | 2. März 2023 S | 290.794 | 0 | 0 | $0 |
| Kristin Yarema | Chief Commercial Officer | 1. März 2022 A | 171.415 | 0 | 0 | $0 |
| Joe Newell | Chief Operations Officer | 16. November 2021 S | 113.097 | 0 | 0 | $0 |
| Dietmar Berger | Global Head of R&D | 7. Mai 2019 F | 85.678 | 0 | 0 | $0 |
| Mina Kim | Senior VP & General Counsel | 9. April 2019 F | 66.389 | 0 | 0 | $0 |
| Derrell Porter | SVP, Head of Global Commercial | 26. März 2019 A | 31.688 | 0 | 0 | $0 |
| Christopher Haqq | EVP, R&D & Chief Scientific Of | 15. Februar 2019 S | 271.943 | 0 | 0 | $0 |
| Gad Soffer | EVP & Chief Strategy Officer | 22. September 2018 F | 243.966 | 0 | 0 | $0 |
| Mitchall G. Clark | EVP & Chief R & QA Officer | 18. Mai 2018 S | 107.972 | 0 | 0 | $0 |
| Heather D Turner | Former EVP, GC & Sec. | 9. Februar 2018 S | 69.494 | 0 | 0 | $0 |
| Brian N Cherry | Direktor | 4. September 2026 P | 166.486 | 1 | 0 | $999.994 |
| Gregory A. Ciongoli | Direktor | 9. Juni 2026 A | 12.000 | 0 | 0 | $0 |
| Matthew K Fust | Direktor | 9. Juni 2026 A | 30.188 | 0 | 0 | $0 |
| William K Heiden | Direktor | 9. Juni 2026 A | 34.188 | 0 | 0 | $0 |
| Ameet Mallik | Direktor | 10. Juni 2025 A | 16.928 | 0 | 0 | $0 |
| Maria Grazia Roncarolo | Direktor | 10. Juni 2025 A | 17.368 | 0 | 0 | $0 |
| Pascal Touchon | Direktor | 10. Juni 2025 A | 77.955 | 0 | 0 | $0 |
| Carol Giltner Gallagher | Direktor | 10. Juni 2025 A | 33.012 | 0 | 0 | $0 |
| Eric Dobmeier | Direktor | 10. November 2023 P | 563.325 | 0 | 0 | $0 |
| Beth C Seidenberg | Direktor | 31. Mai 2023 A | 115.689 | 0 | 0 | $0 |
| Roy D. Baynes | Direktor | 23. Juni 2022 A | 43.500 | 0 | 0 | $0 |
| Ronald C Renaud JR | Direktor | 23. Juni 2022 A | 31.500 | 0 | 0 | $0 |
| Joel S Marcus | Direktor | 15. März 2019 S | 888.355 | 0 | 0 | $0 |
| Eckard Weber | Direktor | 16. Januar 2015 A | · | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10%-Eigentümer | 7. Mai 2026 P | 1.552.000 | 1 | 0 | $4.744.255 |
| Eric J Hyllengren | · | 31. März 2025 D | 56.231 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
ATRA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$13.00
+37,1%
2 20,0%
Starker Kauf
6 60,0%
Kauf
2 20,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-10-02Mittelwert-Ziel $13.67 +44,2%
← Unter allen Zielen
Aktueller Preis $9.48
Tief$10.00
Mittelwert$13.67
Hoch$18.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| CNXU | · | · | · | · | · | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
| GRML | · | · | · | · | -104.9% | · |
| GANX | $135M | -5.3 | -60.6% | · | -181.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026